Know Cancer

or
forgot password

    • cancer clinical trials in reno, NV

    • Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Saint Mary's Regional Medical Center
    Reno, Nevada 89503
    Prostate Cancer
    Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer
    Renown Institute for Cancer at Renown Regional Medical Center
    Reno, Nevada 89502
    Breast Cancer
    Interleukin-2 Plus Histamine Dihydrochloride in Treating Patients With Acute Myeloid Leukemia
    Nevada Medical Group-Internal Medicine
    Reno, Nevada 89502
    Leukemia
    Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer
    Washoe Cancer Services at Washoe Medical Center - Reno
    Reno, Nevada 89502
    Prostate Cancer
    Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)
    Washoe Medical Center
    Reno, Nevada 89520
    Alzheimer Disease
    Interstitial Brachytherapy With or Without External-Beam Radiation Therapy in Treating Patients With Prostate Cancer
    Renown Institute for Cancer at Renown Regional Medical Center
    Reno, Nevada 89502
    Prostate Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Saint Mary's Regional Medical Center

    Trial Locations
    Saint Mary's Regional Medical Center
    Renown Institute for Cancer at Renown Regional Medical Center
    Endometrial Cancer
    Radiation Therapy in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
    Saint Mary's Regional Medical Center

    Trial Locations
    Saint Mary's Regional Medical Center
    Renown Institute for Cancer at Renown Regional Medical Center
    Breast Cancer
    Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
    Renown Institute for Cancer at Renown Regional Medical Center
    Reno, Nevada 89502
    Cervical Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Renown Regional Medical Center
    Reno, Nevada 89502
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Proteomic Profiling in Diagnosing Ovarian Cancer in Patients Who Are Undergoing Surgery for an Abnormal Pelvic Mass
    Washoe Cancer Services at Washoe Medical Center - Reno

    Trial Locations
    Washoe Cancer Services at Washoe Medical Center - Reno
    Saint Mary's Regional Medical Center
    Fallopian Tube Cancer, Ovarian Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Saint Mary's Regional Medical Center

    Trial Locations
    Saint Mary's Regional Medical Center
    Renown Regional Medical Center
    Center of Hope at Renown Medical Center
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Renown Regional Medical Center
    Reno, Nevada 89502
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Saint Mary's Regional Medical Center

    Trial Locations
    Saint Mary's Regional Medical Center
    Radiation Oncology Associates - Reno
    Prostate Cancer
    Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
    Center of Hope at Renown Medical Center
    Reno, Nevada 89502
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Renown Institute for Cancer at Renown Regional Medical Center
    Reno, Nevada 89502
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mL
    VA Sierra Nevada Health Care System
    Reno, Nevada 89502
    NSCLC
    Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
    Renown Regional Medical Center
    Reno, Nevada 89502
    Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Salivary Gland Squamous Cell Carcinoma, Stage IV Salivary Gland Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Tongue Cancer, Untreated Metastatic Squamous Neck Cancer With Occult Primary
    Combination Chemotherapy and Intensity-Modulated Radiation Therapy in Treating Patients Undergoing Surgery for Locally Advanced Rectal Cancer
    Renown Institute for Cancer at Renown Regional Medical Center
    Reno, Nevada 89502
    Colorectal Cancer
    BETH Study: Treatment of HER2 Positive Breast Cancer With Chemotherapy Plus Trastuzumab vs Chemotherapy Plus Trastuzumab Plus Bevacizumab
    Renown Regional Medical Center

    Trial Locations
    Renown Regional Medical Center
    Alpine Hematology-Oncology
    Breast Cancer
    CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
    St. Mary's Regional Medical Center
    Reno, Nevada 89503
    Non-small Cell Lung Cancer
    CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose Distribution
    St. Mary's Regional Medical Center
    Reno, Nevada 89503
    Prostate Cancer, Prostatic Cancer, Prostate Neoplasms, Prostatic Neoplasms, Cancer of the Prostate
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Renown Regional Medical Center

    Trial Locations
    Renown Regional Medical Center
    Center of Hope at Renown Medical Center
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement
    Saint Mary's Regional Medical Center

    Trial Locations
    Saint Mary's Regional Medical Center
    Radiation Oncology Associates - Reno
    Renown Institute for Cancer at Renown Regional Medical Center
    Breast Cancer, Metastatic Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Musculoskeletal Complications, Pain, Prostate Cancer, Urinary Complications
    An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab
    Renown Institute for Neurosciences
    Reno, Nevada
    Multiple Sclerosis, Relapsing-Remitting
    Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    Center of Hope at Renown Medical Center
    Reno, Nevada 89502
    Brenner Tumor, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed Persistent or Recurrent Uterine or Ovarian Cancer
    Renown Institute for Cancer at Renown Regional Medical Center
    Reno, Nevada 89502
    Ovarian Cancer, Sarcoma
    Radiation Therapy With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
    Renown Institute for Cancer at Renown Regional Medical Center
    Reno, Nevada 89502
    Head and Neck Cancer
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Renown Regional Medical Center

    Trial Locations
    Renown Regional Medical Center
    Center of Hope at Renown Medical Center
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    Renown Institute for Cancer at Renown Regional Medical Center
    Reno, Nevada 89502
    Colorectal Cancer, Precancerous Condition
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Center of Hope at Renown Medical Center
    Reno, Nevada 89502
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
    Saint Mary's Regional Medical Center

    Trial Locations
    Saint Mary's Regional Medical Center
    Renown Regional Medical Center
    Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer